Authors: Marvin M. Schuster, MD; Michael D. Crowell, PhD; Nicholas J. Talley, MD, PhDDisclosuresRelease Date: October 26, 2000;
Valid for credit through October 26, 2001 This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.
Since this article was written, specifically on November 28, 2000, the FDA has ordered the withdrawal of Alosetron (Lotronex).